I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
AJM300, a novel oral antagonist of α4‐integrin, sustains an..:
Fukase, Hiroyuki
;
Kajioka, Toshifumi
;
Oikawa, Ichiro
..
British Journal of Clinical Pharmacology. 86 (2020) 3 - p. 591-600 , 2020
Link:
https://doi.org/10.1111/bcp.14151
RT Journal T1
AJM300, a novel oral antagonist of α4‐integrin, sustains an increase in circulating lymphocytes: A randomised controlled trial in healthy male subjects
UL https://suche.suub.uni-bremen.de/peid=cr-10.1111_bcp.14151&Exemplar=1&LAN=DE A1 Fukase, Hiroyuki A1 Kajioka, Toshifumi A1 Oikawa, Ichiro A1 Ikeda, Naoki A1 Furuie, Hidetoshi PB Wiley YR 2020 SN 0306-5251 SN 1365-2125 JF British Journal of Clinical Pharmacology VO 86 IS 3 SP 591 OP 600 LK http://dx.doi.org/https://doi.org/10.1111/bcp.14151 DO https://doi.org/10.1111/bcp.14151 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)